QNRX (Quoin Pharmaceuticals) מחיר לרווח עתידי

QNRX (quoinpharma.com) - סמל מסחרי של החברה

Quoin Pharmaceuticals (QNRX) maintains an impeccable reputation in the therapy of rare dermatoses. The company's forward P/E ratio visualizes this status, where the 0.00 mark indicates the level of investment risk. The brand attracts leading biochemists with generous RSU packages. High profitability is driven by the global sale of patented formulas with minimal production costs.

מכפיל P/E עתידי: Quoin Pharmaceuticals (QNRX) עבור 04.07.2022 - 17.11.2026

quoinpharma.com (QNRX) - פילוחי מדדים ודוחות פיננסיים

- מדדי הערכת שווי שוק של העסק:
ניתוח ראשוני של החברה:Quoin Pharmaceuticals Ltd QNRX
מוצר ממותג של Quoin Pharmaceuticals

Quoin Pharmaceuticals (QNRX) focuses on therapies for ultra-rare dermatological diseases, which, combined with regular equity dilution, complicates profit forecasting. The forward P/E ratio relates the current share price to the expected net income for the following year; therefore, fluctuations in the company's projected P/E reflect the market's reassessment of risks associated with prolonged clinical trials and the volatility of the business's fundamental value.